PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1194126
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1194126
North America Ambulatory Infusion Pumps Market Size Analysis by Product Type, Route of Administration, Application, Distribution Channel - Industry Revenue Estimation and Demand Forecast to 2030
In 2021, the North American ambulatory infusion pumps market was worth around $953.1 million, and it is expected to reach $1,989.8 million by 2030, advancing at an 8.5% CAGR from 2021 to 2030.
The major factors behind the industry growth are the rising geriatric population, snowballing diabetes incidence, surging demand for ambulatory services, and growing prevalence of many other chronic diseases.
The industry growth is also ascribed to the rising awareness about diabetes management and increasing healthcare expenditure. Insulin and obesity resistance have been taken as separate risk factors for diabetes; therefore, the growing obese populace results in a massive demand for insulin delivery devices, which, in turn, boosts the ambulatory infusion pump sales in North America.
Accessories & Consumables Hold Larger Share in Market:
Accessories & consumables capture the larger share of the industry, based on product type. It is ascribed to their repetitive buying and presence of a wide range of accessories & consumables across North America.
In 2021, devices too had a significant market share. This can be credited to the surging demand for such pumps for convenience when taking drugs for a wide range of conditions.
Largest Share Is Captured by Diabetes Application:
Diabetes holds the largest revenue share of the North American ambulatory infusion pumps market, around 30%, based on application. This can be credited to the rising incidence of diabetes and its complications in the region.
Around 96 million people in the age group of 18 and above suffer from prediabetes, which amounts to 38.0% of the adult U.S. population. As insulin needs to be injected at specific times, an infusion pump replaces the need for numerous regular injections with a single constant infusion.
Ambulatory Service Demand Rising Rapidly:
The rising geriatric population and increasing stress on healthcare organizations because of the burgeoning number of patients afflicted with all kinds of diseases are significantly driving the popularity of ambulatory services in the region. This is also ascribed to the low cost of these services and their higher suitability compared to conventional hospital services.
Thus, the count of ambulatory surgical centers in the U.S. has significantly increased in the last few years. The acceptance of ASCs can also be credited to the faster recovery, lower infection risk, shorter stays, and innovative technologies they offer.
The U.S. holds a gigantic share, of over 90%, due to the availability of key players, surging prevalence of chronic diseases, developed healthcare infrastructure, and favorable reimbursement policies. Additionally, the expansion in the count of healthcare settings and the availability of home infusion services propel the industry's growth.
As per the American Hospital Association, 6,093 hospitals were active in the U.S. in 2021, including 2,960 non-government hospitals and 1,228 investor-owned healthcare facilities.
Table of Contents
Chapter 1. Research Background
- 1.1 Research Objectives
- 1.2 Market Definition
- 1.3 Analysis Period
- 1.4 Market Size Breakdown by Segments
- 1.4.1 Market Segmentation by Product Type
- 1.4.2 Market Segmentation by Route of Administration
- 1.4.3 Market Segmentation by Application
- 1.4.4 Market Segmentation by Distribution Channel
- 1.4.5 Market Segmentation by Country
- 1.5 Market Data Reporting Unit
- 1.5.1 Value
- 1.6 Key Stakeholders
Chapter 2. Research Methodology
- 2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
- 2.1.3 P&S Intelligence Database
- 2.2 Primary Research
- 2.2.1 Breakdown of Primary Research, by Industry Participant
- 2.2.2 Breakdown of Primary Research, by Designation
- 2.2.3 Breakdown of Primary Research, by Company Type
- 2.3 Market Size Estimation
- 2.4 Data Triangulation
- 2.5 Currency Conversion Rates
- 2.6 Assumptions for the Study
- 2.7 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Definition of Market Segments
- 4.1 By Product Type
- 4.1.1 Devices
- 4.1.2 Accessories & Consumables
- 4.2 By Route of Administration
- 4.2.1 Intravenous
- 4.2.2 Subcutaneous
- 4.2.3 Epidural
- 4.3 By Application
- 4.3.1 Pain Management
- 4.3.2 Diabetes
- 4.3.3 Oncology
- 4.3.4 Neonatology
- 4.3.5 Gastroenterology
- 4.3.6 General Anesthesia
- 4.3.7 Emergency Medicine
- 4.3.8 Others
- 4.4 By Distribution Channel
- 4.4.1 Direct
- 4.4.2 Indirect 32
Chapter 5. Industry Outlook
- 5.1 Market Dynamics
- 5.1.1 Trends
- 5.1.1.1 Launch of new products
- 5.1.1.2 Growing significance of home infusion therapies
- 5.1.2 Drivers
- 5.1.2.1 Surging prevalence of chronic diseases
- 5.1.2.2 Rising geriatric population
- 5.1.2.3 Increasing diabetic population
- 5.1.2.4 Growing demand for ambulatory services
- 5.1.3 Impact Analysis of Drivers on Market Forecast
- 5.1.3.1 Disadvantages associated with infusion pumps
- 5.1.3.2 High cost of infusion pumps
- 5.1.4 Impact Analysis of Restraints on Market Forecast
- 5.1.1 Trends
- 5.2 Impact of COVID-19
- 5.3 Porter's Five Forces Analysis
- 5.3.1 Bargaining Power of Buyers
- 5.3.2 Bargaining Power of Suppliers
- 5.3.3 Threat of New Entrants
- 5.3.4 Intensity of Rivalry
- 5.3.5 Threat of Substitutes
Chapter 6. North America Ambulatory Infusion Pumps Market Size and Forecast
- 6.1 Overview
- 6.2 Market Revenue, by Product Type (2017-2030)
- 6.3 Market Revenue, by Route of Administration (2017-2030)
- 6.4 Market Revenue, by Application (2017-2030)
- 6.5 Market Revenue, by Distribution Channel (2017-2030)
- 6.6 Market Revenue, by Country (2017-2030)
Chapter 7. Competitive Landscape
- 7.1 List of Market Players and Their Offerings
- 7.2 Competitive Benchmarking of Key Players
- 7.3 Product Benchmarking of Key Players
- 7.4 Recent Strategic Developments of Key Players
Chapter 8. Company Profiles
- 8.1 B. Braun Melsungen AG
- 8.1.1 Business Overview
- 8.1.2 Product and Service Offerings
- 8.1.3 Key Financial Summary
- 8.2 MOOG Inc.
- 8.2.1 Business Overview
- 8.2.2 Product and Service Offerings
- 8.2.3 Key Financial Summary
- 8.3 WalkMed LLC
- 8.3.1 Business Overview
- 8.3.2 Product and Service Offerings
8.4. Medtronic plc
8.4.1. Business Overview
8.4.2. Product and Service Offerings
8.4.3. Key Financial Summary
- 8.5 Fresenius Medical Care AG & Co. KGaA (Fresenius Kabi)
- 8.5.1 Business Overview
- 8.5.2 Product and Service Offerings
- 8.5.3 Key Financial Summary
- 8.6 Becton, Dickinson and Company
- 8.6.1 Business Overview
- 8.6.2 Product and Service Offerings
- 8.6.3 Key Financial Summary
- 8.7 Repro Med Systems Inc. (KORU Medical Systems)
- 8.7.1 Business Overview
- 8.7.2 Product and Service Offerings
- 8.7.3 Key Financial Summary
- 8.8 Avanos Medical Inc.
- 8.8.1 Business Overview
- 8.8.2 Product and Service Offerings
- 8.8.3 Key Financial Summary
- 8.9 ICU Medical Inc.
- 8.9.1 Business Overview
- 8.9.2 Product and Service Offerings
- 8.9.3 Key Financial Summary
- 8.10 Eitan Medical
- 8.10.1 Business Overview
- 8.10.2 Product and Service Offerings
- 8.11 Ace Medical Co. Ltd.
- 8.11.1 Business Overview
- 8.11.2 Product and Service Offerings
- 8.12 InfuTronix LLC
- 8.12.1 Business Overview
- 8.12.2 Product and Service Offerings
- 8.13 Baxter International Inc.
- 8.13.1 Business Overview
- 8.13.2 Product and Service Offerings
- 8.13.3 Key Financial Summary
Chapter 9. Appendix
- 9.1 Abbreviations
- 9.2 Sources and References
- 9.3 Related Reports
List of Tables
- TABLE 1 ANALYSIS PERIOD OF THE STUDY
- TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
- TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
- TABLE 4 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY PRODUCT TYPE, $M (2017-2021)
- TABLE 5 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY PRODUCT TYPE, $M (2022-2026)
- TABLE 6 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY PRODUCT TYPE, $M (2027-2030)
- TABLE 7 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY ROUTE OF ADMINISTRATION, $M (2017-2021)
- TABLE 8 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY ROUTE OF ADMINISTRATION, $M (2022-2026)
- TABLE 9 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY ROUTE OF ADMINISTRATION, $M (2027-2030)
- TABLE 10 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY APPLICATION, $M (2017-2021)
- TABLE 11 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY APPLICATION, $M (2022-2026)
- TABLE 12 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY APPLICATION, $M (2027-2030)
- TABLE 13 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2017-2021)
- TABLE 14 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2022-2026)
- TABLE 15 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2027-2030)
- TABLE 16 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY COUNTRY, $M (2017-2021)
- TABLE 17 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY COUNTRY, $M (2022-2026)
- TABLE 18 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY COUNTRY, $M (2027-2030)
- TABLE 19 LIST OF MARKET PLAYERS AND THEIR OFFERINGS
- TABLE 20 COMPETITIVE BENCHMARKING OF KEY PLAYERS
- TABLE 21 PRODUCT BENCHMARKING OF KEY PLAYERS
- TABLE 22 B. BRAUN MELSUNGEN AG - AT A GLANCE
- TABLE 23 B. BRAUN MELSUNGEN AG - KEY FINANCIAL SUMMARY
- TABLE 24 MOOG INC. - AT A GLANCE
- TABLE 25 MOOG INC. - KEY FINANCIAL SUMMARY
- TABLE 26 WALKMED LLC - AT A GLANCE
- TABLE 27 MEDTRONIC PLC - AT A GLANCE
- TABLE 28 MEDTRONIC PLC - KEY FINANCIAL SUMMARY
- TABLE 29 FRESENIUS MEDICAL CARE AG & CO. KGAA (FRESENIUS KABI)- AT A GLANCE
- TABLE 30 FRESENIUS MEDICAL CARE AG & CO. KGAA (FRESENIUS KABI) - KEY FINANCIAL SUMMARY
- TABLE 31 BECTON, DICKINSON AND COMPANY - AT A GLANCE
- TABLE 32 BECTON, DICKINSON AND COMPANY - KEY FINANCIAL SUMMARY
- TABLE 33 REPRO MED SYSTEMS INC. (KORU MEDICAL SYSTEMS)- AT A GLANCE
- TABLE 34 REPRO MED SYSTEMS INC. (KORU MEDICAL SYSTEMS) - KEY FINANCIAL SUMMARY
- TABLE 35 AVANOS MEDICAL INC. - AT A GLANCE
- TABLE 36 AVANOS MEDICAL INC. - KEY FINANCIAL SUMMARY
- TABLE 37 ICU MEDICAL INC. - AT A GLANCE
- TABLE 38 ICU MEDICAL INC. - KEY FINANCIAL SUMMARY
- TABLE 39 EITAN MEDICAL - AT A GLANCE
- TABLE 40 ACE MEDICAL CO. LTD. - AT A GLANCE
- TABLE 41 INFUTRONIX LLC - AT A GLANCE
- TABLE 42 BAXTER INTERNATIONAL INC. - AT A GLANCE
- TABLE 43 BAXTER INTERNATIONAL INC. - KEY FINANCIAL SUMMARY
List of Figures
- FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
- FIG 2 RESEARCH METHODOLOGY
- FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
- FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
- FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
- FIG 6 DATA TRIANGULATION APPROACH
- FIG 7 CURRENCY CONVERSION RATES FOR USD (2021)
- FIG 8 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET SUMMARY
- FIG 9 CANCER DEATHS IN U.S., BY LOCATION (2022)
- FIG 10 BARGAINING POWER OF BUYERS
- FIG 11 BARGAINING POWER OF SUPPLIERS
- FIG 12 THREAT OF NEW ENTRANTS
- FIG 13 INTENSITY OF RIVALRY
- FIG 14 THREAT OF SUBSTITUTES
- FIG 15 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET SNAPSHOT
- FIG 16 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY PRODUCT TYPE, $M (2017-2030)
- FIG 17 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY ROUTE OF ADMINISTRATION, $M (2017-2030)
- FIG 18 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY APPLICATION, $M (2017-2030)
- FIG 19 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2017-2030)
- FIG 20 NORTH AMERICA AMBULATORY INFUSION PUMPS MARKET REVENUE, BY COUNTRY, $M (2017-2030)
- FIG 21 B. BRAUN MELSUNGEN AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
- FIG 22 MOOG INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
- FIG 23 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
- FIG 24 FRESENIUS MEDICAL CARE AG & CO. KGAA (FRESENIUS KABI) - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
- FIG 25 BECTON, DICKINSON AND COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
- FIG 26 AVANOS MEDICAL INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
- FIG 27 ICU MEDICAL INC. - REVENUE SPLIT BY PRODUCT LINE AND GEOGRAPHY (2021)
- FIG 28 BAXTER INTERNATIONAL INC. - REVENUE SPLIT BY GBU AND GEOGRAPHY (2020)
